Anesa Mulabecirovic

Anesa Mulabecirovic, MD PhD MBA, currently serves as DNB Healthcare and DNB Biotechnology at DNB Asset Management since June 2021. Previously, Anesa worked as an Investment Professional at Hadean Ventures and as an Expert Evaluator for The Research Council of Norway, contributing to the evaluation of applications for commercialisation projects. Anesa held leadership roles as President of the Norwegian Society for Diagnostic Ultrasound in Medicine and as a Board Member of the European Society of Ultrasound (EFSUMB). Anesa has a strong background in gastroenterology, with experience as a Project Manager at Helse Vest and board member of the National Advisory Unit for Ultrasound in Gastroenterology. Academic credentials include a PhD from the University of Bergen and King's College London, an MD from Universität zu Lübeck, and an MBA from the Norwegian School of Economics.